Status:
COMPLETED
Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Caisse Nationale de Solidarité pour l'Autonomie
National Health Insurance Fund for Unemployed Workers
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
ETNA3 is a multicentric randomised clinical trial conducted in France to evaluate the impact of cognitive training, reminiscence therapy and a "made-to-measure" program on the progression rate of deme...
Detailed Description
ETNA3 is a multicentric randomised clinical trial conducted in France to evaluate the impact of non pharmacological treatments on the progression rate of dementia: Three non pharmacological treatments...
Eligibility Criteria
Inclusion
- Patients in the mild to moderate stages of Alzheimer's Disease : MMSE score between 16 and 26 ; and stages 3 to 5 of the Global Deterioration Scale
- Patients over 50 years of age
- Patients with social security affiliation
Exclusion
- Patients suffering other type of dementia
- Institutionalized patients
- Patients with psychiatric disorder
- Patients with severe pathology in the terminal stages
- Patients receiving non pharmacological therapies other than that proposed in the study
- Enrollment in a pharmacological trial in the first 6 months
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
640 Patients enrolled
Trial Details
Trial ID
NCT00646269
Start Date
March 1 2008
End Date
December 1 2012
Last Update
August 1 2013
Active Locations (39)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Agen
Agen, France, 47923
2
CHU Amiens Nord
Amiens, France, 80054
3
Centre Mémoire de Ressources et de Recherches de Bordeaux, CHU de Bordeaux
Bordeaux, France, 33076
4
Hôpital Pellegrin
Bordeaux, France, 33076